How could the study of patients under anesthesia lead to a new way to diagnose Alzheimer’s disease? It could all come down to brainwaves.
Blog
Huntington’s disease (HD) is a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain.
Gastroenterology, Neurology, Population Health & Outcomes, Psychiatry | 0 comment | 3 November, 2017 | 0
The people we encounter early in life can often have a profound impact on our future. For Massachusetts General Hospital psychologist Dr. Kamryn Eddy, a childhood friend influenced her career trajectory.
Reigning in Alzheimer’s disease continues to be a challenge — more than 10 million families are affected by this degenerative neurological disease, and the number of patients dying from the disease has increased 68 percent since 2010. In the past decade, attempts at developing drugs to slow or halt the progression of Alzheimer’s disease haveRead more
Researchers from MIT and Mass General recently unveiled a wireless, portable system for monitoring individuals during sleep that could provide new insights into sleep disorders and reduce the need for time and cost-intensive overnight sleep studies in a clinical sleep lab.
Please join us in congratulating the four Mass General investigators who recently received director’s awards from the National Institutes of Health (NIH)!
Researchers at Massachusetts General Hospital are using brain imaging technology to learn more about how individuals with autism and schizophrenia view the world through different lenses.
Lady Gaga recently discussed her struggles with fibromyalgia. Here’s what Mass General researchers are doing to learn more about this disorder.
The Institute for Brain Health at Mass General is revolutionizing the way we treat brain disease by developing new strategies for prevention, risk reduction and early treatment.
Mass General researchers have developed a new forecasting model that has the potential to pinpoint when a migraine will strike by tracking an individual’s stress levels over time.